Manuel Pera
Overview
Explore the profile of Manuel Pera including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
93
Citations
1873
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Pelc Z, Sedlak K, Endo Y, Van Sandick J, Gisbertz S, Pera M, et al.
Am J Surg
. 2025 Feb;
242:116235.
PMID: 39954554
Introduction: Palliative chemotherapy is the current standard among advanced gastric cancer (GC) patients with peritoneal metastasis (PM), while the role of gastrectomy with cytoreductive surgery and HIPEC remains unclear. The...
2.
Markar S, Mariette C, Bonnetain F, Lundell L, Rosati R, De Manzoni G, et al.
Dis Esophagus
. 2025 Jan;
38(1.
PMID: 39863958
Background: Malnutrition is common with esophagogastric cancers and is associated with negative outcomes. We aimed to evaluate if immunonutrition during neoadjuvant treatment improves patient's health-related quality of life (HRQOL) and...
3.
Schneider M, Kim J, Berlth F, Sugita Y, Grimminger P, Wijnhoven B, et al.
Ann Surg
. 2024 Aug;
280(5):788-798.
PMID: 39101212
Objective/background: Various anastomotic and reconstruction techniques are used for minimally invasive total (miTG) and distal gastrectomy (miDG). Their effects on postoperative morbidity have not been extensively studied. Methods: MiTG and...
4.
Dal Cero M, Gibert J, Grande L, Gimeno M, Osorio J, Bencivenga M, et al.
Cancers (Basel)
. 2024 Jul;
16(13).
PMID: 39001525
Background: Radical gastrectomy remains the main treatment for gastric cancer, despite its high mortality. A clinical predictive model of 90-day mortality (90DM) risk after gastric cancer surgery based on the...
5.
Tur-Martinez J, Rodriguez-Santiago J, Osorio J, Miro M, Yarnoz C, Jofra M, et al.
Cancers (Basel)
. 2024 Jun;
16(12).
PMID: 38927894
The aim of this study was to evaluate different preoperative immune, inflammatory, and nutritional scores and their best cut-off values as predictors of poorer overall survival (OS) and disease-free survival...
6.
Benaiges D, Goday A, Casajoana A, Flores-Le Roux J, Fito M, Pozo O, et al.
Cardiovasc Diabetol
. 2024 Jun;
23(1):205.
PMID: 38879559
Background: There has been a substantial increase in the use of laparoscopic sleeve gastrectomy (SG) to treat morbid obesity despite observational evidence demonstrating the superiority of Roux-en-Y gastric bypass (RYGB)...
7.
Kroese T, Bronzwaer S, van Rossum P, Schoppman S, Deseyne P, Van Cutsem E, et al.
Eur J Cancer
. 2024 Apr;
204:114062.
PMID: 38678762
Introduction: The OligoMetastatic Esophagogastric Cancer (OMEC) project aims to provide clinical practice guidelines for the definition, diagnosis, and treatment of esophagogastric oligometastatic disease (OMD). Methods: Guidelines were developed according to...
8.
Visser M, Voeten D, Gisbertz S, Ruurda J, Achiam M, Nilsson M, et al.
Dis Esophagus
. 2024 Apr;
37(9).
PMID: 38670807
Reasons for structural and outcome differences in esophageal cancer surgery in Western Europe remain unclear. This questionnaire study aimed to identify differences in the organization of esophageal cancer surgical care...
9.
Henckens S, Schuring N, Elliott J, Johar A, Markar S, Gantxegi A, et al.
Ann Surg
. 2024 Apr;
280(2):267-273.
PMID: 38577796
Objective: To determine the impact of operative approach [open (OE), hybrid minimally invasive (HMIE), and total minimally invasive (TMIE) esophagectomy] on operative and oncologic outcomes for patients treated with curative...
10.
Goday A, Bagan A, Casajoana A, Serra C, Pera M, Villatoro M, et al.
Obes Surg
. 2024 Feb;
34(4):1196-1206.
PMID: 38400943
Purpose: To assess the effects of Helicobacter pylori (HP) eradication with an omeprazole, clarithromycin, amoxicillin, and metronidazole (OCAM) regimen on the metabolic profile and weight loss 12 months after bariatric...